Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This chemical compound, identified by its IUPAC-like name (3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol, is a complex organic molecule with the molecular formula C15H28N2O5. It is listed in chemical databases such as PubChem (with a closely related stereoisomer having CID 46937123). However, there is no publicly available information regarding its specific pharmacological properties, mechanism of action, therapeutic indications, or development status as a pharmaceutical drug. It is likely a research chemical or an intermediate compound, rather than a drug currently in clinical development or on the market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol.